Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization

Y Jiang, W Ni - … : The Journal of Human Pharmacology and …, 2015 - Wiley Online Library
Study Objective To estimate the impact of adherence to and persistence with atypical
antipsychotics on health care costs and risk of hospitalization by controlling potential …

Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications

IS Al-Zakwani, JJ Barron, MF Bullano… - … medical research and …, 2003 - Taylor & Francis
Objective: To examine the effects of typical and atypical antipsychotics on medication
adherence and healthcare resource utilization. Research design and methods: This was a …

Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia

T Dilla, A Ciudad, M Alvarez - Patient preference and adherence, 2013 - Taylor & Francis
Purpose There is strong evidence supporting the link between nonadherence to
antipsychotic medication and relapse of schizophrenia. However, less obvious are the …

Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia

S Offord, J Lin, D Mirski, B Wong - Advances in therapy, 2013 - Springer
Introduction To quantify early nonadherence to antipsychotic medications in patients with
schizophrenia and its impact on short-term antipsychotic adherence, healthcare utilization …

Patterns of adherence to oral atypical antipsychotics among patients diagnosed with schizophrenia

JP MacEwan, FM Forma, J Shafrin, A Hatch… - Journal of managed …, 2016 - jmcp.org
BACKGROUND: Poor medication adherence contributes to negative treatment response,
symptom relapse, and hospitalizations in schizophrenia. Many health plans use claims …

Rates and predictors of antipsychotic non-adherence and hospitalization in Medicaid and commercially-insured patients with schizophrenia

K Lang, V Federico, E Muser, J Menzin… - Journal of Medical …, 2013 - Taylor & Francis
Objective: To assess rates and predictors of antipsychotic non-adherence and
hospitalizations among patients with schizophrenia in separate Medicaid and commercial …

Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients.

TB Gibson, Y Jing, E Kim, E Bagalman… - … care (Langhorne, Pa …, 2010 - europepmc.org
Cost-sharing effects on adherence and persistence for second-generation antipsychotics in
commercially insured patients. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics

D Pilon, M Alcusky, Y Xiao… - Journal of Medical …, 2018 - Taylor & Francis
Aims: This study compared healthcare resource utilization (HRU), healthcare costs,
adherence, and persistence among adult patients with schizophrenia using once-monthly …

Assessment of compliance with antipsychotic treatmentand resource utilization in a medicaid population

M Eaddy, A Grogg, J Locklear - Clinical Therapeutics, 2005 - Elsevier
BACKGROUND:: Partial compliance with mental healthmedications has been associated
with an increased risk of clinical worsening, relapse, and repeat hospitalization …

Role of patient experience in atypical antipsychotic adherence: a retrospective data analysis

M Vanelli, M Coca-Perraillon, A Troxell-Dorgan - Clinical therapeutics, 2007 - Elsevier
Objective: We report on differences in atypical antipsychotic adherence after the start of
outpatient treatment with atypical antipsychotics in patients receiving routine clinical care …